Takashi Harada

Takashi Harada

Auto-generated profile, based on publicly available information

Takashi Harada

Department of Obstetrics and Gynecology Tottori University Faculty of Medicine Yonago Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
THTakashi Harada
Takashi Harada
Fuminori TaniguchiFuminori Taniguchi
Fuminori Taniguchi
THTasuku Harada
Tasuku Harada
Background: Reproductive‐age women occasionally face the pathological condition of adenomyosis, which is often concurrent with endometriosis. It is believed that endometriosis and adenomyosis increases the risk of obstetric complications. Although new insights into the mechanism of obstetric complications due to endometriosis are emerging, there is little information on the etiology of adverse pregnancy outcomes in pregnant women with adenomyosis.Methods: We performed a literature review focusing on the pathophysiological pathways of obstetric complications in women with adenomyosis using currently available basic and clinical studies. We used the internet search engines PubMed and Google Scholar to search for studies published between January 2000 and June 2021. We carefully read pertinent sections within each document to ensure relevancy.Main findings: The prevalence of adverse pregnancy outcomes in women with adenomyosis is increased after adjusting for conceiving by assisted reproductive technology. Thus, adenomyosis emerges as a relevant factor associated with several obstetric complications such as preterm birth, preterm premature rupture of membranes, placental abruption, small for gestational age/fetal growth restriction, and preeclampsia.Conclusion: It is plausible that the impact of adenomyosis on pregnancy outcomes is not always the same; rather it is dependent on the degree of uterine involvement and subtypes.

1 August 1995 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
STS. Tajima
S. Tajima
KSK. Shimizu
K. Shimizu
TIT. Izumi
T. Izumi
SKSho Kurihara
Sho Kurihara
THT. Harada
T. Harada

1 January 2017 in Yonago Acta Medica
Verified
Journal Article
Open access
PDF file
Fuminori TaniguchiFuminori Taniguchi
Fuminori Taniguchi
AEAkiko Enatsu
Akiko Enatsu
AIAi Ikebuchi
Ai Ikebuchi
EYEmiko Yamane
Emiko Yamane
MMMaako Moriyama
Maako Moriyama
THTasuku Harada
Tasuku Harada
Endometriosis is a chronic inflammatory disorder associated with pelvic pain and infertility. Because surgical and medical therapies control symptoms, but it is hard to cure completely endometriosis, long term of pharmacologic management is necessary. Norethisterone (NET), one of progestins, has safety profile and advantage that allow long-term use. In this preliminary report, we showed the efficacy of NET in 6 patients with endometriosis. The size of ovarian endometrioma was decreased after treatment with NET for 6 months, and all patients were relieved from dysmenorrhea pain within 6 months, suggesting that NET would be a suitable medication to treat endometriosis.

1 January 1992 in Journal of Japanese Society for Dialysis Therapy
Verified
Journal Article
Open access
PDF file
KTKoichi Taura
Koichi Taura
KTKazuhiko Takashima
Kazuhiko Takashima
RYRyoukichi Yasumori
Ryoukichi Yasumori
SKShigehiro Kubota
Shigehiro Kubota
YOYoshiyuki Oozono
Yoshiyuki Oozono
KHKohei Hara
Kohei Hara
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。